The boom in weight-loss drugs is set to provide a boost to sportswear brands and clothing retailers, according to Deutsche Bank AG analysts.
Slimmer people will likely need to purchase smaller sizes and will be motivated to exercise more to keep the weight off, analyst Adam Cochrane wrote in a note.
He identified sports wear makers Adidas AG and Puma AG as potential beneficiaries, along with apparel retailers Inditex SA, Hennes & Mauritz A/S…